Chair: GlaxoSmithKline Partnered (2007-2008)

GlaxoSmithKline Inc. (GSK) and the CIHR/Rx&D Collaborative Research Program are pleased to announce the results of the "Chair: GlaxoSmithKline Partnered (2007-2008)" competition.

The specific objectives of this collaboration are:

• to provide attractive, long-term personnel awards;
• to promote recruitment and retainment of highly-qualified personnel;
• to establish Chairs in disciplines where specific universities are particularly strong, and where GSK and CIHR have clear scientific interest; e.g., therapeutic areas respiratory medicine, virology, oncology; related fields that are important to specific elements of development and commercialization, such as pharmaceutics, clinical pharmacology, functional genomics, and structural biology; and emerging research areas that include social sciences, such as health outcomes.

One (1) application was submitted in March 2008. The application was reviewed by the University-Industry peer review committee resulting in its approval for funding.

[ HTML | PDF (84 KB) | Help ]

Name / Institution / Title	Total CIHR Contribution	Total Partner Contribution	Term (yrs)
CHAPMAN, Kenneth University of Toronto	$218,000	$218.000	5